Genenta Science S.p.A. (GNTA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.69M | -6.02M | -4.18K | -2.06K | -3.62K | -7.51M | -4.85M | -2.57M | -2.27M | -4.69M | -4.1M | -1.25M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -40323.96% | -292586.49% | -15.4% | 99.97% | 99.93% | -192.63% | -114% | 45.29% | 44.71% | - | -229.38% | - |
| Net Income | -2.68M | -4.18M | -8.91M | -4.04K | -4.89K | -6.7M | -6.37M | -2.11M | -1.48M | -4.05M | -3.11M | -2.3M |
| Depreciation & Amortization | 14.04K | 15.23K | 44.5K | 22 | 21 | 20.95K | 3.33K | 2.81K | 2.8K | 2.09K | 1.33K | 0 |
| Stock-Based Compensation | 0 | 424 | 847.02K | 233 | 323 | 208 | 482.69K | 240.04K | 0 | 497.1K | 230.1K | 374.76K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -42.1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 466.53K | 583.83K | 6.3M | 161 | 22 | 493.76K | 734.26K | 360.27K | -160.49K | -191.43K | -881.9K | 2.43K |
| Working Capital Changes | 512.13K | -2.44M | 1.72M | 1.56K | 894 | -1.29M | 293.12K | -1.06M | -628.19K | -950.73K | -337.93K | 676.58K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 32.08K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13.79K |
| Cash from Investing | -10.31M | -4.85M | 2.58K | 4.3K | -4.89K | -9.91M | -24.26K | -2.81K | -5.28K | -3.73K | -7.68K | 0 |
| Capital Expenditures | -480 | -8.33K | -4.47K | -2.02K | -1.48K | -12.32K | -24.26K | -2.81K | -5.28K | -3.73K | -7.68K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -6.88M | 4.3K | -4.89K | -5K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 12.38M | 11.44M | 270.61K | 271 | 0 | 0 | 0 | 0 | 28.96M | -216.74K | 1.39M | 7.38M |
| Debt Issued (Net) | 472.8K | 8.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -172 | 0 | 7.54M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -172 | 0 | 0 |
| Other Financing | 11.91M | 3.25M | 270.61K | 271 | 0 | 0 | 0 | 0 | 28.96M | -216.57K | 1.39M | -159.25K |
| Net Change in Cash | 353.53K | 1.33M | 4.58M | 6.19K | -12.21K | -17.42M | -2.44M | -1.28M | 13.34M | -2.46M | -1.36M | 12.28M |
| Free Cash Flow | -1.69M | -6.03M | -6.24M | -2.06K | -3.63K | -7.52M | -4.88M | -2.57M | -2.27M | -4.69M | -4.11M | -1.25M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 72.91% | -292706.8% | -172061.64% | 99.97% | 99.93% | -192.79% | -114.57% | 45.28% | 44.69% | - | -230% | - |
| FCF per Share | -0.08 | -0.32 | -0.34 | -0.00 | -0.00 | -0.41 | -0.27 | -0.14 | -0.15 | -0.32 | -0.28 | -0.07 |
| FCF Conversion (FCF/Net Income) | 0.63x | 1.69x | 0.00x | 0.00x | 0.00x | 1.12x | 0.76x | 1.21x | 1.53x | 1.16x | 1.32x | 0.54x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |